WallachBeth Capital Announces Closing of bioAffinity Technologies Warrant Inducement Transaction for Aggregate Gross Proceeds of $1.4 Million

Group 1 - bioAffinity Technologies, Inc. has closed warrant exercise agreements with four accredited investors, resulting in the exercise of 2,438,473 shares of common stock for gross cash proceeds of approximately $1.4 million [1][2] - In exchange for the immediate exercise of existing warrants, the investors will receive new unregistered warrants to purchase up to 2,926,166 shares of common stock at an exercise price of$0.85 per share, which is 120% of the shares issued from the existing warrants [1] - The exercise price of the existing warrants has been reduced from $1.50 to$0.58 per share as part of this transaction [1] Group 2 - WallachBeth Capital is acting as the sole placement agent for the warrant inducement transaction [2] - The gross proceeds from the warrant inducement are expected to be approximately $1.4 million, excluding any proceeds from the exercise of the new warrants and before deducting placement agent fees and other offering expenses [2]